Corazon (Corsee) D. Sanders Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

Corazon (Corsee) D. Sanders is of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 12,009 shares of RARE, which is worth approximately $521,430. The most recent transaction as insider was on Jul 02, 2024, when has been sold 584 shares (Common Stock) at a price of $40.98 per share, resulting in proceeds of $23,932. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12K

0% 3M change

33.66% 12M change

Total Value Held $521,430

Corazon (Corsee) D. Sanders Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 02 2024	SELL Open market or private sale	$23,932 $40.98 p/Share	584 Reduced 4.64%	12,009 Common Stock
Jun 18 2024	BUY Grant, award, or other acquisition	-	5,345 Added 29.8%	12,593 Common Stock
Jun 10 2024	SELL Open market or private sale	$71,390 $41.1 p/Share	1,737 Reduced 19.33%	7,248 Common Stock
Jun 30 2023	SELL Open market or private sale	$27,354 $46.76 p/Share	585 Reduced 6.11%	8,985 Common Stock
Jun 08 2023	SELL Open market or private sale	$76,700 $51.65 p/Share	1,485 Reduced 13.43%	9,570 Common Stock
Jun 07 2023	BUY Grant, award, or other acquisition	-	3,860 Added 25.88%	11,055 Common Stock
Jun 24 2022	BUY Grant, award, or other acquisition	-	3,300 Added 31.44%	7,195 Common Stock
Jun 29 2021	BUY Grant, award, or other acquisition	-	3,895 Added 50.0%	3,895 Common Stock

Also insider at

BGNE

BeiGene, Ltd. Healthcare

Director

MTEM

Molecular Templates, Inc. Healthcare

C(D